FDA-Drug2025-09-24Class II
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226
Hazard
Lack of Assurance of Sterility
Sold states
USA nationwide.
Affected count
109,320 syringes
Manufactured in
8710 E 34th St N, N/A, Wichita, KS, United States
Products
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0646-2025More Fagron Compounding Services recalls
- FDA-Drug2026-04-15Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01
- FDA-Drug2026-04-15Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01
- FDA-Drug2026-04-15Fagron norepinephrine injection recalled for sterility concerns and port defect
- FDA-Drug2026-04-15Fagron norepinephrine injection recalled for sterility concerns and port defect
- FDA-Drug2026-04-15Fagron Vancomycin HCL IV bags recalled for sterility and port defect risk
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief